期刊文献+

RANKL/RANK/OPG系统与强直性脊柱炎相关性研究进展 被引量:3

下载PDF
导出
作者 王玉 徐胜前
出处 《医学研究杂志》 2010年第6期117-120,共4页 Journal of Medical Research
基金 安徽省高校省级自然科学研究项目(KJ2007B137)
  • 相关文献

参考文献27

  • 1Lorenzo J,Horowitz M,Choi Y.Osteoimmunology:interactions of the bone and immune system.Endocr Rev,2008,29(4):403-440.
  • 2Wada T,Nakashima T,Hiroshi N,et al.RANKL-RANK signaling in osteoclastogenesis and bone disease.Trends Mol Med,2006,12(1):17-25.
  • 3Hikita A,Yana I,Wakeyama H,et al.Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand.J Biol Chem,2006,281(48):36846-36855.
  • 4Leibbrandt A,Penninger JM.RANK/RANKL:regulators of immune responses and bone physiology.Ann N Y Acad Sci,2008,143(1):123-150.
  • 5Miller PD.Denosumab:anti-RANKL antibody.Curr Osteoporos Rep,2009,7(1):18-22.
  • 6Lloyd SA,Yuan YY,Kostenuik PJ,et al.Soluble RANKL induces high bone turnover and decreases bone volume,density,and strength in mice.Calcif Tissue Int.2008,82(5):361-372.
  • 7Bekker PJ,Holloway D,Nakanishi A,et al.The effect of a single dose of osteoprotegerin in postmenopausal women.J Bone Miner Res,2001,16(2):348-360.
  • 8Miranda-Carús ME,Benito-Miguel M,Balsa A,et al.Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promoteoste oclastogenesis in autologous monocytes.Arthritis Rheum,2006,54(4):1151-1164.
  • 9Kearns AE,Khosla S,Kostenuik PJ.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Endocr Rev,2008,29(2):155-192.
  • 10Wright HL,McCarthy HS,Middleton J,et al.RANK,RANKL and osteoprotegerin in bone biology and disease.Curr Rev Musculoskelet Med,2009,2(1):56-64.

二级参考文献60

  • 1刘红,廖二元,伍贤平.骨钙素与代谢性骨病[J].国外医学(内分泌学分册),2004,24(4):239-240. 被引量:44
  • 2褚洪涛,张百安.云克与松梅乐治疗强直性脊柱炎疗效对比观察[J].中国误诊学杂志,2004,4(3):418-419. 被引量:19
  • 3阿孜古丽,王丽,陈程,杨忠礼,邵红,刘早玲.儿童强直性脊柱炎HLA-B27抗原表达与骨损害关系的临床研究[J].中国校医,2006,20(1):25-26. 被引量:2
  • 4杨春花,黄烽.强直性脊柱炎免疫遗传学和发病机制研究进展[J].现代免疫学,2007,27(4):265-269. 被引量:12
  • 5Gravallese EM, Manning C, Tsay A et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum, 2000, 43:250
  • 6Kayanagi H, Iizuka H, Juji T et al. Involvement of receptor activator of nuclear factor κB ligand osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum, 2000, 43:259
  • 7Yukio S, Thomas P, Peter K et al. Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum, 2000, 43: 2523
  • 8Takayanagi H, Iizuka H, Juji T et al. Involvement of receptor activator of nuclear factor κB ligand osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum, 2000, 43:259
  • 9Toussirot E, Ricard-Blum S, Dumoulin G et al. Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis. Rheumatol (Oxford), 1999, 38:21
  • 10Toussirot E, Michel F, Auge B et al. Bone mass, body composition and bone ultrasound measurements in ankylosing spondylitis. Arthritis Rheum, 1999, 42(suppl): S356

共引文献40

同被引文献21

引证文献3

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部